Xue Guanhua, Wang Qinning, Yan Chao, Jeoffreys Neisha, Wang Liqiong, Li Shaoli, Gilbert Gwendolyn L, Sun Hongmei
Department of Bacteriology, Capital Institute of Pediatrics, Beijing, China.
J Clin Microbiol. 2014 May;52(5):1478-82. doi: 10.1128/JCM.03366-13. Epub 2014 Feb 26.
Mycoplasma pneumoniae is an important cause of community-acquired pneumonia (CAP). In this study, M. pneumoniae strains in PCR-positive specimens collected from patients in Sydney, Australia (30 samples), and Beijing, China (83 samples), were characterized using multilocus variable-number tandem-repeat (VNTR) analysis (MLVA), P1-restriction fragment length polymorphism (RFLP) analysis, and sequencing of domain V of the 23S rRNA gene to compare genotype distribution and macrolide resistance rates between locations. Eighteen distinct MLVA types were identified in specimens from Sydney, of which 10 were known (types E, G, J, M, N, P, U, V, S, and X) and 8 previously unknown. Strains were equally distributed between P1-RFLP type 1 and type 2 variants. Among samples from Beijing, MLVA types E, G, J, P, U, X, and Z and four new types were identified. Most specimens belonged to P1-RFLP type 1. A nomenclature based on five VNTR loci is proposed to designate MLVA patterns. Macrolide resistance-associated mutations were identified in only 1 of 30 specimens (3.3%) from Sydney and 71 of 83 (85.5%) from Beijing (P<0.05). This study demonstrated that although multiple individual M. pneumoniae strains were circulating in Beijing, the genotypes were less diverse than those in Sydney. However, the greatest regional difference was in the incidence of macrolide resistance, which may reflect differences in antibiotic use and/or measures in resistance control.
肺炎支原体是社区获得性肺炎(CAP)的重要病因。在本研究中,采用多位点可变数目串联重复序列(VNTR)分析(MLVA)、P1限制性片段长度多态性(RFLP)分析以及23S rRNA基因V区测序,对从澳大利亚悉尼(30份样本)和中国北京(83份样本)患者中收集的PCR阳性标本中的肺炎支原体菌株进行特征分析,以比较不同地区的基因型分布和大环内酯类耐药率。在悉尼的标本中鉴定出18种不同的MLVA类型,其中10种是已知的(E、G、J、M、N、P、U、V、S和X型),8种是以前未知的。菌株在P1-RFLP 1型和2型变体之间均匀分布。在北京的样本中,鉴定出MLVA类型E、G、J、P、U、X和Z以及四种新类型。大多数标本属于P1-RFLP 1型。提出了一种基于五个VNTR位点的命名法来指定MLVA模式。在悉尼30份标本中仅1份(3.3%)和北京83份标本中的71份(85.5%)鉴定出与大环内酯类耐药相关的突变(P<0.05)。本研究表明,尽管北京有多种肺炎支原体菌株在传播,但基因型的多样性低于悉尼。然而,最大的地区差异在于大环内酯类耐药率。这可能反映了抗生素使用和/或耐药控制措施的差异。